Live Breaking News & Updates on Apellis Pharmaceuticals Stock Down

Stay updated with breaking news from Apellis pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KPP Advisory Services LLC Has $670,000 Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

KPP Advisory Services LLC raised its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 17.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,196 shares of the company’s stock after buying an additional 1,675 shares during the quarter. KPP […] ....

Timothy-eugene-sullivan , Mark-jeffrey-delong , Piper-sandler , Exchange-commission , Securities-exchange-commission , News-ratings-for-apellis-pharmaceuticals-daily , Citigroup , Wynnefield-capital-inc , Charles-schwab-investment-management-inc , Quarter-for-apellis-pharmaceuticals , Apellis-pharmaceuticals-inc , Nasdaq

KPP Advisory Services LLC Raises Stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

KPP Advisory Services LLC boosted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 17.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,196 shares of the company’s stock after purchasing an additional 1,675 shares during the quarter. KPP Advisory Services LLC’s […] ....

Timothy-eugene-sullivan , Pascal-deschatelets , Apellis-pharmaceuticals-stock-down , Norges-bank , Needham-company , Wells-fargo-company , Apellis-pharmaceuticals , Advisory-services , Fiera-capital-corp , Polar-capital-holdings-plc , Insider-activity-at-apellis-pharmaceuticals , Jpmorgan-chase-co

Rhenman & Partners Asset Management AB Decreases Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Rhenman & Partners Asset Management AB lessened its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 53.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 100,400 shares of the company’s stock after selling 114,600 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Apellis Pharmaceuticals were […] ....

Piper-sandler , Timothy-eugene-sullivan , Mark-jeffrey-delong , Apellis-pharmaceuticals-profile , Asset-management-group , Covestor-ltd , Whittier-trust-co , Apellis-pharmaceuticals-stock-down , Nasdaq , Jpmorgan-chase-co , Quarter-for-apellis-pharmaceuticals , Securities-exchange-commission

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0.42) Per Share, Wedbush Forecasts

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0.42) Per Share, Wedbush Forecasts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China , Pascal-deschatelets , Timothy-eugene-sullivan , Securities-exchange-commission , Institutional-trading-of-apellis-pharmaceuticals , Apellis-pharmaceuticals-stock-down , Covestor-ltd , News-ratings-for-apellis-pharmaceuticals-daily , Nasdaq , China-universal-asset-management-co , Apellis-pharmaceuticals , Citigroup

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

Needham & Company LLC Reiterates Buy Rating for Apellis Pharmaceuticals (NASDAQ:APLS)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Adamj-townsend , Davido-watson , Jennison-associates , Apellis-pharmaceuticals-stock-down , Apellis-pharmaceuticals , Apellis-pharmaceuticals-inc , Needham-company , Pricet-rowe-associates-inc , News-ratings-for-apellis-pharmaceuticals-daily , Analyst-recommendations-for-apellis-pharmaceuticals , Polar-capital-holdings-plc